This multidisciplinary consensus statement, which was published in the February 2018 issue of Transfusion Medicine with open access, provides recommendations on the management of anaemia and haematinic... Read More
Anaesthesia, the journal of the Association of Anaesthetists of Great Britain & Ireland, announces the publication of a special open-access supplement on Transfusion, Thrombosis and Management... Read More
On September 25, 2014, Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and... Read More
On May 22, 2014, Boehringer Ingelheim announced the next step in the clinical development of idarucizumab, an investigational antidote for rapid reversal of dabigatran-induced anticoagulation.... Read More
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.